The program highlights for BayOConnect 2026 – Forum for Biotech & LifeScience are now available. As one of Europe’s key networking and partnering events for the biotechnology and life sciences sector, BayOConnect brings together leaders from research, industry, start-ups, investment and policy to discuss innovation pathways and shape the future of biomedicine.
Two Days, Clear Focus: From Biotech Strategy to TechBio Innovation
The two-day conference offers a well-structured program addressing current challenges and opportunities across the life science ecosystem:
30 June – Driving Biotech in Europe focuses on financing strategies for biotech innovation, success stories from the European and Bavarian start-up landscape, regulatory and clinical development perspectives, and international collaboration, including a dedicated partner country session with Austria.
1 July – Innovation Across TechBio highlights enabling technologies for next-generation healthcare solutions, the role of translational research and innovation clusters, future perspectives from leading pharma players, and a Pre-Seed & Early-Stage Startup Pitch session.
Together, these sessions reflect the breadth and momentum of biotech innovation – from venture capital and regulation to digital and data-driven life sciences.
Renowned Speakers from Science, Industry and Regulation
The BayOConnect 2026 speaker line-up features renowned experts and decision-makers from academia, industry associations, regulatory consulting and innovation management.
Confirmed speakers include:
Prof. Dr. Thomas Brück – Technical University of Munich
Dr. Ulrich Granzer – Granzer Regulatory Consulting & Services
Prof. Dr. Simon Jacob – TUM University Hospital Rechts der Isar / TUM School of Medicine and Health
Dr. med. Kai Joachimsen – General Manager, German Pharmaceutical Industry Association (BPI)
Prof. Dr. Ludwig Christian Hinske – Director Institute of Digital Medicine, University of Augsburg
Prof. Dr. Ralf Huss – Managing Director, BioM Biotech Development GmbH
Dr. Matthias Meergans – Executive Director R&D, Association of Research-Based Pharmaceutical Companies (vfa)
A Key Platform for the European Biotech Ecosystem
Over the years, BayOConnect has established itself as a flagship event for the Bavarien biotech community and around Europe, fostering dialogue between established companies, emerging start-ups, investors and academic innovators. The conference provides a platform for knowledge exchange, strategic partnerships, and forward-looking discussions on biomedical innovation.
Further details on the program, speakers and registration are available at www.bayoconnect.org.